久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/11/18 | 3,735 | 3,815 | 3,735 | 3,815 | +90 | +2.4% | 231,500 |
2022/11/17 | 3,660 | 3,745 | 3,660 | 3,725 | +70 | +1.9% | 154,500 |
2022/11/16 | 3,590 | 3,675 | 3,575 | 3,655 | +65 | +1.8% | 180,400 |
2022/11/15 | 3,580 | 3,615 | 3,580 | 3,590 | +15 | +0.4% | 122,200 |
2022/11/14 | 3,575 | 3,605 | 3,570 | 3,575 | -25 | -0.7% | 135,600 |
2022/11/11 | 3,660 | 3,660 | 3,600 | 3,600 | ±0 | ±0% | 126,000 |
2022/11/10 | 3,590 | 3,610 | 3,535 | 3,600 | +15 | +0.4% | 135,200 |
2022/11/09 | 3,640 | 3,640 | 3,585 | 3,585 | -55 | -1.5% | 81,300 |
2022/11/08 | 3,665 | 3,675 | 3,615 | 3,640 | +10 | +0.3% | 131,500 |
2022/11/07 | 3,580 | 3,665 | 3,575 | 3,630 | +120 | +3.4% | 175,700 |
2022/11/04 | 3,540 | 3,555 | 3,505 | 3,510 | -80 | -2.2% | 140,700 |
2022/11/02 | 3,595 | 3,640 | 3,560 | 3,590 | -20 | -0.6% | 181,400 |
2022/11/01 | 3,680 | 3,680 | 3,600 | 3,610 | -60 | -1.6% | 97,100 |
2022/10/31 | 3,690 | 3,730 | 3,645 | 3,670 | +30 | +0.8% | 169,600 |
2022/10/28 | 3,600 | 3,695 | 3,565 | 3,640 | -15 | -0.4% | 563,900 |
2022/10/27 | 3,685 | 3,690 | 3,635 | 3,655 | -30 | -0.8% | 201,600 |
2022/10/26 | 3,615 | 3,695 | 3,615 | 3,685 | +105 | +2.9% | 188,000 |
2022/10/25 | 3,615 | 3,625 | 3,575 | 3,580 | +35 | +1% | 179,500 |
2022/10/24 | 3,680 | 3,680 | 3,530 | 3,545 | -70 | -1.9% | 267,700 |
2022/10/21 | 3,630 | 3,650 | 3,580 | 3,615 | -20 | -0.6% | 164,600 |
2022/10/20 | 3,660 | 3,680 | 3,605 | 3,635 | -65 | -1.8% | 230,700 |
2022/10/19 | 3,715 | 3,730 | 3,675 | 3,700 | -45 | -1.2% | 201,200 |
2022/10/18 | 3,780 | 3,780 | 3,705 | 3,745 | +20 | +0.5% | 216,600 |
2022/10/17 | 3,785 | 3,810 | 3,700 | 3,725 | -35 | -0.9% | 371,100 |
2022/10/14 | 3,795 | 3,835 | 3,725 | 3,760 | -45 | -1.2% | 459,800 |
2022/10/13 | 3,610 | 3,880 | 3,580 | 3,805 | +460 | +13.8% | 1,107,800 |
2022/10/12 | 3,365 | 3,390 | 3,345 | 3,345 | -20 | -0.6% | 131,500 |
2022/10/11 | 3,365 | 3,405 | 3,355 | 3,365 | -60 | -1.8% | 190,900 |
2022/10/07 | 3,380 | 3,445 | 3,380 | 3,425 | +5 | +0.1% | 153,200 |
2022/10/06 | 3,445 | 3,475 | 3,420 | 3,420 | -30 | -0.9% | 167,300 |
2022/10/05 | 3,485 | 3,495 | 3,430 | 3,450 | -35 | -1% | 152,900 |
2022/10/04 | 3,410 | 3,495 | 3,410 | 3,485 | +145 | +4.3% | 289,300 |
2022/10/03 | 3,350 | 3,375 | 3,310 | 3,340 | -55 | -1.6% | 184,300 |
2022/09/30 | 3,420 | 3,465 | 3,385 | 3,395 | -20 | -0.6% | 204,200 |
2022/09/29 | 3,345 | 3,420 | 3,330 | 3,415 | +120 | +3.6% | 213,700 |
2022/09/28 | 3,270 | 3,310 | 3,265 | 3,295 | +30 | +0.9% | 248,700 |
2022/09/27 | 3,260 | 3,285 | 3,230 | 3,265 | +10 | +0.3% | 218,800 |
2022/09/26 | 3,265 | 3,285 | 3,240 | 3,255 | -30 | -0.9% | 229,800 |
2022/09/22 | 3,300 | 3,310 | 3,260 | 3,285 | -50 | -1.5% | 176,600 |
2022/09/21 | 3,365 | 3,380 | 3,335 | 3,335 | -55 | -1.6% | 137,100 |
2022/09/20 | 3,460 | 3,460 | 3,390 | 3,390 | -35 | -1% | 110,000 |
2022/09/16 | 3,385 | 3,430 | 3,385 | 3,425 | +15 | +0.4% | 103,100 |
2022/09/15 | 3,400 | 3,425 | 3,385 | 3,410 | +10 | +0.3% | 82,100 |
2022/09/14 | 3,410 | 3,430 | 3,395 | 3,400 | -80 | -2.3% | 133,600 |
2022/09/13 | 3,485 | 3,505 | 3,445 | 3,480 | -25 | -0.7% | 127,000 |
2022/09/12 | 3,545 | 3,545 | 3,485 | 3,505 | +5 | +0.1% | 112,300 |
2022/09/09 | 3,470 | 3,515 | 3,470 | 3,500 | +30 | +0.9% | 217,600 |
2022/09/08 | 3,410 | 3,480 | 3,400 | 3,470 | +80 | +2.4% | 242,000 |
2022/09/07 | 3,425 | 3,430 | 3,350 | 3,390 | -30 | -0.9% | 173,700 |
2022/09/06 | 3,420 | 3,460 | 3,410 | 3,420 | -15 | -0.4% | 95,000 |
601~
650
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム